A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain

  1. González-Juanatey, J.R.
  2. González-Franco, Á.
  3. de Sequera, P.
  4. Valls, M.
  5. Ramirez de Arellano, A.
  6. Pomares, E.
  7. Nieves, D.
Journal:
Journal of Medical Economics

ISSN: 1941-837X 1369-6998

Year of publication: 2022

Volume: 25

Issue: 1

Pages: 640-649

Type: Article

DOI: 10.1080/13696998.2022.2074193 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals